Wells Fargo Maintains Overweight on Adient, Lowers Price Target to $28

Benzinga Newsdesk www.benzinga.com Negative 85.3%

Neg 85.3% Neu 0% Pos 0%

Wells Fargo analyst Colin Langan maintains Adient (NYSE:ADNT) with a Overweight and lowers the price target from $29 to $28.